Biotech Startups

UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations. This page presents the company's corporate governance structure, including its Board of Directors and Executive Committee.

3 investors

Radicle Science runs clinical trials and evidence-generation studies for wellness products—including supplements, food and beverage, and pet wellness—using large, demographically diverse datasets, DTC tests, wearables, and AI analysis. It offers a "Proof-as-a-Service" platform for brands seeking science-backed claims across health areas via RCTs, open-label, and in-home use tests.

3 investors

Rainstick develops weather-event and biotech-related technology, drawing on hardware and software engineering. The page focuses on the team but indicates the company works at the intersection of agriculture, biotech, and transformative technology.

3 investors

Rasyn.ai offers Marigold, an AI research assistant that lets scientists ask research questions, run tools, or delegate entire tasks, returning results such as structures, charts, code, and papers in panels. It provides 54 runnable tools, 40 executing on connected hardware and 14 on hosted endpoints.

3 investors

Rational Vaccines is a biotech company focused on the herpes simplex virus (HSV-1 and HSV-2), addressing conditions such as genital and oral herpes, neonatal HSV, ocular herpes, and HSV-related complications in immunocompromised patients. This page is an educational overview of herpes rather than a product listing.

3 investors

A biopharmaceutical company developing therapies for neurology, immunology, and rare diseases. The page describes work focused on treating hard-to-treat conditions.

3 investors

Re-Fresh Global pioneers textile waste recycling solutions using biotechnology to transform discarded textiles into new, sustainable resources. The company serves textile manufacturers and waste management operators in Europe and globally, addressing regulatory demand for circular textile economy solutions.

3 investors

Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform. It serves researchers analyzing gene expression at subcellular resolution, including in FFPE and degraded samples.

3 investors

Rebel Medicine develops preclinical investigational drugs and wound care products designed to provide pain relief without opioids. The company targets postoperative and wound care patients through patented drug delivery technologies for local anesthetic applications.

3 investors

ReBio develops targeted, locally delivered therapies for ocular oncology, using its proprietary SiSu conjugate platform to program drug exposure for eye diseases. Its lead program, RBP-01, is a SiSu-conjugated PKC inhibitor for uveal melanoma delivered via intravitreal injection, with additional programs targeting retinoblastoma, glaucoma, and post-op ocular inflammation.

3 investors

Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.

3 investors

Rectify Pharma is a biotechnology company developing therapies, with a pipeline that has included work in liver and metabolic disease areas. This page profiles a member of its executive team.

3 investors

Redona Therapeutics is a drug discovery company co-founded by Harvard Medical School investigators focused on novel areas of biology. The company is led by experienced biotech executives with backgrounds in immunology, oncology, and translational medicine.

3 investors

Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets. The company also maintains an oncology pipeline with partnered and in-house programs for unmet medical needs.

3 investors

ReGelTec develops injectable hydrogel technology for the repair of the nucleus pulposus of the intervertebral disc, targeting interventional pain management and spine care. The company is a medical device (MedTech) startup combining academic research in crosslinked polymers with experienced medical device executives.

3 investors

Regenosine develops regenerative medicine therapies for musculoskeletal and orthopedic conditions. The company leverages adenosine-based science to address inflammatory diseases and tissue healing.

3 investors

Related Sciences assembles distributed teams of academic experts and industry veterans to conduct specialized drug discovery and research for biotech companies. The company operates a decentralized R&D model where leading scientists work collaboratively on targeted therapeutic programs.

3 investors

Reliant AI builds AI systems designed to understand life sciences data and support strategic decision-making in drug development for biopharmaceutical companies. Its tools provide predictive and search capabilities over large-scale academic and research data for pharma and biotech commercial and research teams.

3 investors

Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring. It targets heart failure patients with diuretic-resistant congestion whose needs are inadequately met by pharmaceuticals and legacy devices.

3 investors

3 investors

RenovoRx is a life sciences company developing targeted drug delivery for cancer treatment, including its TAMP therapy approach. It operates as a publicly listed biopharmaceutical/medical device company focused on oncology.

3 investors

Reselute is a privately held medical device company developing orthopedic implant systems that combine structural fixation with controlled local drug delivery. Its lead investigational product targets high-risk tibial fractures where infection is a persistent complication, embedding sustained local antibiotic release within a load-bearing implant.

3 investors

Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases. It holds an exclusive worldwide license from NYU Langone Health for related intellectual property.

3 investors

ResistanceBio develops treatments to address drug resistance in cancer patients.

3 investors